UnknownPhase 4NCT00274885
Relationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal Cancer
Studying Adenocarcinoma of the anal canal
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- GERCOR - Multidisciplinary Oncology Cooperative Group
- Principal Investigator
- Philippe LechatCHU Pitie-Salpetriere
- Intervention
- oxaliplatin(drug)
- Enrollment
- 58 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2005
Study locations (6)
- CHU de Grenoble - Hopital Michallon, Grenoble, France
- Centre Hospital Universitaire Hop Huriez, Lille, France
- Clinique Saint Jean, Lyon, France
- Hopital Saint Antoine, Paris, France
- CHU Pitie-Salpetriere, Paris, France
- Hopital Tenon, Paris, France
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00274885 on ClinicalTrials.govOther trials for Adenocarcinoma of the anal canal
Additional recruiting or active studies for the same condition.